South Wales, Sept. 17 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "Crucible Therapeutics" on June 10. The details about the trademark application no. UK00004216979 published in the journal no. 2025/035 (Aug. 29).
CRUCIBLE THERAPEUTICS LIMITED filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; Pharmaceutical preparations for the prevention of diseases of the nervous system; Pharmaceutical preparations for the prevention of disorders of the nervous system; Immunoassay reagents for medical use; Medical diagnostic reagents and assays for testing of body fluids; Diagnostic biomarker reagents for medical purposes; In vitro diagnostic preparations for medical use; Pharmaceuticals.
Class 42 : Scientific research relating to biology; Scientific research in the field of genetics; Biotechnology research; Biological research, clinical research and medical research; Scientific research relating to genetics; Biotechnology research for determining the neuronal survival of molecules in animal models; Scientific research and development; Pharmaceutical research and development; Research in the field of gene therapy; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the pharmaceutical and biotechnology fields; Research and development for the pharmaceutical industry; Research relating to biotechnology.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004216979
Disclaimer: Curated by HT Syndication.
